Protocol to request
            
                Evaluation of CRISPRi/a cell lines using sgRNAs targeting individual genes
                
                
            
        
        
            
                Research article
            
            
                A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity
                
            
            
            
                Adam C Palmer et al.
            
            
                DOI: 10.7554/eLife.50036